CD33
Basic information
Region (hg38): 19:51225064-51243860
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD33 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 17 | 10 | 31 | |||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 18 | 7 | 16 |
Variants in CD33
This is a list of pathogenic ClinVar variants found in the CD33 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-51225119-A-G | Uncertain significance (Sep 01, 2017) | |||
19-51225219-G-A | Benign (Jul 31, 2018) | |||
19-51225221-C-T | Benign (Aug 22, 2019) | |||
19-51225256-C-G | not specified | Uncertain significance (Jan 29, 2024) | ||
19-51225269-C-T | not specified | Uncertain significance (May 12, 2024) | ||
19-51225289-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
19-51225311-T-C | Benign (Jul 16, 2018) | |||
19-51225317-C-CCATAAA | CD33-related disorder | Uncertain significance (Jul 15, 2024) | ||
19-51225331-G-A | not specified | Uncertain significance (Sep 27, 2022) | ||
19-51225344-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
19-51225361-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
19-51225365-G-A | CD33-related disorder | Likely benign (Jun 05, 2018) | ||
19-51225373-G-C | Benign (Dec 13, 2017) | |||
19-51225385-A-G | Benign (Aug 22, 2019) | |||
19-51225451-C-T | not specified | Uncertain significance (Dec 13, 2022) | ||
19-51225502-G-A | not specified | Uncertain significance (Mar 11, 2022) | ||
19-51225517-A-G | not specified | Uncertain significance (Feb 17, 2024) | ||
19-51225530-T-A | not specified | Uncertain significance (Dec 19, 2023) | ||
19-51225535-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
19-51225559-T-C | Likely benign (Jan 01, 2023) | |||
19-51225563-G-A | Benign (May 15, 2018) | |||
19-51225590-A-G | Benign (May 15, 2018) | |||
19-51225806-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
19-51225839-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
19-51225847-CCCGG-C | CD33-related disorder | Benign (Aug 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD33 | protein_coding | protein_coding | ENST00000262262 | 7 | 18796 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.69e-7 | 0.441 | 121860 | 57 | 3831 | 125748 | 0.0156 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.141 | 211 | 205 | 1.03 | 0.0000109 | 2328 |
Missense in Polyphen | 43 | 46.914 | 0.91657 | 583 | ||
Synonymous | 0.540 | 81 | 87.4 | 0.927 | 0.00000515 | 768 |
Loss of Function | 0.698 | 11 | 13.8 | 0.797 | 5.87e-7 | 161 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0356 | 0.0346 |
Ashkenazi Jewish | 0.00120 | 0.00119 |
East Asian | 0.000275 | 0.000272 |
Finnish | 0.00361 | 0.00361 |
European (Non-Finnish) | 0.0250 | 0.0249 |
Middle Eastern | 0.000275 | 0.000272 |
South Asian | 0.00124 | 0.00121 |
Other | 0.0189 | 0.0186 |
dbNSFP
Source:
- Function
- FUNCTION: Putative adhesion molecule of myelomonocytic-derived cells that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Induces apoptosis in acute myeloid leukemia (in vitro). {ECO:0000269|PubMed:10556798, ECO:0000269|PubMed:11320212}.;
- Pathway
- Hematopoietic cell lineage - Homo sapiens (human);Neutrophil degranulation;Innate Immune System;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Recessive Scores
- pRec
- 0.0812
Intolerance Scores
- loftool
- 0.981
- rvis_EVS
- 2.29
- rvis_percentile_EVS
- 98.31
Haploinsufficiency Scores
- pHI
- 0.0350
- hipred
- N
- hipred_score
- 0.166
- ghis
- 0.388
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0558
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd33
- Phenotype
- homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- immune response-inhibiting signal transduction;cell adhesion;signal transduction;cell-cell signaling;negative regulation of cell population proliferation;neutrophil degranulation;regulation of immune response
- Cellular component
- nucleus;plasma membrane;integral component of plasma membrane;external side of plasma membrane;specific granule membrane;tertiary granule membrane
- Molecular function
- protein binding;protein phosphatase binding;carbohydrate binding;signaling receptor activity